Advertisement
Advertisement
TXG
10x Genomics, Inc. Class A Common Stock
81.55
USDSponsored
-2.07
-2.48%
Oct 29, 15:59 UTC -4
Closed
After-Market
82.36
+0.81
+0.99%
10x Genomics, Inc. Class A Common Stock (TXG) Earnings
TXG Earnings Reports
Positive Surprise Ratio
TXG beat 16 of 28 last estimates.
57%
Next Report
Next Week
Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
$149.34M
/-$0.26
Implied change from Q2 26 (Revenue/ EPS)
-1.12%
/+85.71%
Implied change from Q3 25 (Revenue/ EPS)
+0.23%
/+18.18%
10x Genomics, Inc. Class A Common Stock earnings per share and revenue
On Aug 06, 2026, TXG reported earnings of -0.14 USD per share (EPS) for Q2 26, beating the estimate of -0.24 USD, resulting in a 43.09% surprise. Revenue reached 151.04 million, compared to an expected 148.26 million, with a 1.88% difference. The market reacted with a +14.10% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 16 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 149.34 million USD, implying an increase of 85.71% EPS, and decrease of -1.12% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Butterfly Network, Inc.
Report Date
Oct 29, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.01
Surprise
+84.18%
Omnicell Inc
Report Date
Oct 29, 2026 For Q3 26
Estimate
$0.42
Actual
$0.57
Surprise
+36.18%
Pulmonx Corporation Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.19
Surprise
+27.40%
FAQ
What were 10x Genomics, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, 10x Genomics, Inc. Class A Common Stock reported EPS of -$0.14, beating estimates by 43.09%, and revenue of $151.04M, 1.88% above expectations.
How did the market react to 10x Genomics, Inc. Class A Common Stock's Q2 2026 earnings?
The stock price moved up 14.1%, changed from $45.60 before the earnings release to $52.03 the day after.
When is 10x Genomics, Inc. Class A Common Stock expected to report next?
The next earning report is scheduled for Nov 05, 2026.
What are the forecasts for 10x Genomics, Inc. Class A Common Stock's next earnings report?
Based on 16
analysts, 10x Genomics, Inc. Class A Common Stock is expected to report EPS of -$0.26 and revenue of $149.34M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.